The Expert Advisory Committee on Cells, Tissues and Organs is a standing committee formed to provide the Biologics and Genetic Therapies Directorate (the Directorate) with timely advice on issues under federal responsibility for ensuring the safety, quality and efficacy of cells, tissues, and organs, as therapeutic products intended for transplantation. Collectively, the Committee members provide health professional and related expertise and advice pertaining to risk/benefit assessments conducted by others within Health Canada, to assist the Biologics and Genetic Therapies Directorate with making appropriate risk management decisions. The decision-making responsibility remains with the Biologics and Genetic Therapies Directorate.
The inaugural Meeting of the EAC-CTO was held on September 15, 2005.
Please note that only meeting notes from the past three years are posted and that previous meeting notes are available upon request from the Biologics and Genetic Therapies Directorate at BGTD_DGO_Enquiries@hc-sc.gc.ca